TechInvention partners with Eubiologics to launch oral cholera vaccine in LDPE unidose pack in India
83 million doses of Cholera vaccine will be required in India by 2025
TechInvention Lifecare India has tied up with Eubiologics Co, South Korea, to bring in Euvichol-Plus, Oral Cholera Vaccine (OCV) in low-density polyethylene (LDPE) unidose pack.
The company informed through a statement, “Euvichol-Plus is prequalified by World Health Organization (WHO). Eubiologics has so far supplied fifty-five million doses to UN (United Nations) healthcare agencies. Euvichol-Plus has been supplied to around twenty-two countries across the globe. The LDPE unidose pack of Euvichol-Plus is not only easy and safe to use, but also reduces the issues pertaining to conventional glass vials in terms of breakage, storage, transportation and wastage management.”
Syed Ahmed, Founder & CEO, TechInvention said, “It is our endeavour to bring in a WHO Pre Qualified OCV in India for managing potential outbreak risk caused due to the often-neglected disease like cholera. We wish to play our part in supporting Indian Govt’ & WHO’s initiative of ‘Ending Cholera- Global Roadmap by 2030’, by offering affordable, easy to use, safe & efficacious vaccine”.
Yeong-Ok Baik, CEO, Eubiologics, mentioned, “The collaboration between Eubiologics and Techinvention is aimed at reducing the disease burden and saving lives of Indian children by effective vaccination through our WHO-Prequalified cholera vaccine, Euvichol-Plus, in a unidose pack. We are looking forward to the commencement of Phase 3 clinical trial and its successful completion so that the vaccine becomes available for use.”